Needle-free vaccine delivery platform aims to end frozen storage needs and improve access CEPI to initially provide up to US$1.6 million to aVaxziPen to advance development of needle-free vaccine technology aVaxziPen’s innovative vaccine delivery platform aims to improve access to...

aVaxziPen Announces Positive Data in Multiple Diseases on Novel Needle-Free Vaccine, Thermally Stable Delivery Platform at World Vaccine Congress OXFORD, United Kingdom, April 03, 2023 (GLOBE NEWSWIRE) -- aVaxziPen, a biotech company developing a novel needle-free vaccine delivery platform, announces the presentation of data at the World...